In addition, several immunohistochemical analyses demonstrated that ESRP1 expression is significantly associated with poor prognosis in prostate cancer [58–60], suggesting that ESRP1 plays a pro-tumorigenic role. This evidence concerns the gene ESRP1 and prostate carcinoma.